Medical Innovation Exchange

breakthrough designation

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot     Beginning October 1, 2023, the FDA’s Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot will expand to include the Office of Neurological and Physical Medicine Devices (OHT5). The FDA’s Center for Devices and Radiological Health (CDRH) developed the voluntary Total Product Life …

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot Read More »

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot     Beginning October 1, 2023, the FDA’s Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot will expand to include Neurological and Physical Medicine Devices. The FDA’s Center for Devices and Radiological Health (CDRH) developed the voluntary Total Product Life Cycle (TPLC) Advisory Program …

FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot Read More »